Through research in the Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic is leading scientific advances in multiple sclerosis treatment.
A new study shows stimulating the vagus nerve in mice with colitis reduced stress-driven symptoms of inflammatory bowel disease by regulating SUMOylation, an immune response that triggers gut ...
A pioneering clinical trial in Cambridge is bringing renewed hope to those living with multiple sclerosis (MS), a condition where the immune system mistakenly attacks the protective covering of ...
A groundbreaking new treatment for multiple sclerosis is set to begin clinical trials in Greece by mid-2024, offering hope to ...
In a first-of-its-kind trial, physicians will review neurofilament test results with patients and decide whether to continue ...
A relatively easy way to encourage your Black patients with MS to participate in clinical research is to introduce them to ...
PTNS, an electrical impulse treatment for overactive bladder, eased bladder and sexual issues for female RRMS patients in a ...
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
Systemic sclerosis presents significant unmet needs, as current treatments largely target only its interstitial lung disease (ILD) component,” said Robert Lisicki, CEO of Zura Bio. “Tibulizumab, with ...
Adds to growing body of evidence supporting the potential of ITK inhibition as a novel therapeutic for the treatment of a wide range of immune ...
The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback